APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gatifloxacin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gatifloxacin Market Analysis and Forecast 2026-2032

31 December 2025195 pages

Choose your research edition.

Industry ResearchGatifloxacin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Gatifloxacin Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Gatifloxacin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gatifloxacin Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Gatifloxacin Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Gatifloxacin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gatifloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gatifloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gatifloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gatifloxacin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gatifloxacin include Teva Pharmaceuticals, Sandoz, Mylan, Pacific Pharma, Lupin Pharmaceuticals, Hi Tech Pharmacal, Bristol-Myers Squibb, Apotex and Allergan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gatifloxacin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gatifloxacin, also provides the sales of main regions and countries. Of the upcoming market potential for Gatifloxacin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gatifloxacin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gatifloxacin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gatifloxacin sales, projected growth trends, production technology, application and end-user industry.

Gatifloxacin Segment by Company

Teva Pharmaceuticals

Sandoz

Mylan

Pacific Pharma

Lupin Pharmaceuticals

Hi Tech Pharmacal

Bristol-Myers Squibb

Apotex

Allergan

Gatifloxacin Segment by Type

Capsule

Tablet

Aqueous Solution

Others

Gatifloxacin Segment by Application

Synthetic Antibacterial

Ophthalmic Medicine

Other

Gatifloxacin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gatifloxacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gatifloxacin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gatifloxacin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gatifloxacin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gatifloxacin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gatifloxacin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gatifloxacin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Aqueous Solution Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Gatifloxacin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Synthetic Antibacterial Major Manufacturers Table 8. Ophthalmic Medicine Major Manufacturers Table 9. Other Major Manufacturers Table 10. Gatifloxacin Industry Trends Table 11. Gatifloxacin Industry Drivers Table 12. Gatifloxacin Industry Opportunities and Challenges Table 13. Gatifloxacin Industry Restraints Table 14. Global Gatifloxacin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Gatifloxacin Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Gatifloxacin Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Gatifloxacin Revenue Market Share by Region (2021-2026) Table 18. Global Gatifloxacin Revenue Market Share by Region (2027-2032) Table 19. Global Gatifloxacin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gatifloxacin Sales by Region (2021-2026) & (K Units) Table 21. Global Gatifloxacin Sales by Region (2027-2032) & (K Units) Table 22. Global Gatifloxacin Sales Market Share by Region (2021-2026) Table 23. Global Gatifloxacin Sales Market Share by Region (2027-2032) Table 24. Global Gatifloxacin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Gatifloxacin Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Gatifloxacin Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Gatifloxacin Sales Market Share by Manufacturers (2021-2026) Table 28. Global Gatifloxacin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Gatifloxacin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Gatifloxacin Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Gatifloxacin Manufacturers, Product Type & Application Table 32. Global Gatifloxacin Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Gatifloxacin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Gatifloxacin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gatifloxacin Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Gatifloxacin Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Gatifloxacin Revenue Market Share by Type (2021-2026) Table 39. Global Gatifloxacin Revenue Market Share by Type (2027-2032) Table 40. Global Gatifloxacin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Gatifloxacin Sales by Type (2021-2026) & (K Units) Table 42. Global Gatifloxacin Sales by Type (2027-2032) & (K Units) Table 43. Global Gatifloxacin Sales Market Share by Type (2021-2026) Table 44. Global Gatifloxacin Sales Market Share by Type (2027-2032) Table 45. Global Gatifloxacin Price by Type (2021-2026) & (US$/Unit) Table 46. Global Gatifloxacin Price by Type (2027-2032) & (US$/Unit) Table 47. Global Gatifloxacin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gatifloxacin Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Gatifloxacin Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Gatifloxacin Revenue Market Share by Application (2021-2026) Table 51. Global Gatifloxacin Revenue Market Share by Application (2027-2032) Table 52. Global Gatifloxacin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Gatifloxacin Sales by Application (2021-2026) & (K Units) Table 54. Global Gatifloxacin Sales by Application (2027-2032) & (K Units) Table 55. Global Gatifloxacin Sales Market Share by Application (2021-2026) Table 56. Global Gatifloxacin Sales Market Share by Application (2027-2032) Table 57. Global Gatifloxacin Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gatifloxacin Price by Application (2027-2032) & (US$/Unit) Table 59. Teva Pharmaceuticals Company Information Table 60. Teva Pharmaceuticals Business Overview Table 61. Teva Pharmaceuticals Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Teva Pharmaceuticals Gatifloxacin Product Portfolio Table 63. Teva Pharmaceuticals Recent Development Table 64. Sandoz Company Information Table 65. Sandoz Business Overview Table 66. Sandoz Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sandoz Gatifloxacin Product Portfolio Table 68. Sandoz Recent Development Table 69. Mylan Company Information Table 70. Mylan Business Overview Table 71. Mylan Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Mylan Gatifloxacin Product Portfolio Table 73. Mylan Recent Development Table 74. Pacific Pharma Company Information Table 75. Pacific Pharma Business Overview Table 76. Pacific Pharma Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pacific Pharma Gatifloxacin Product Portfolio Table 78. Pacific Pharma Recent Development Table 79. Lupin Pharmaceuticals Company Information Table 80. Lupin Pharmaceuticals Business Overview Table 81. Lupin Pharmaceuticals Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Lupin Pharmaceuticals Gatifloxacin Product Portfolio Table 83. Lupin Pharmaceuticals Recent Development Table 84. Hi Tech Pharmacal Company Information Table 85. Hi Tech Pharmacal Business Overview Table 86. Hi Tech Pharmacal Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hi Tech Pharmacal Gatifloxacin Product Portfolio Table 88. Hi Tech Pharmacal Recent Development Table 89. Bristol-Myers Squibb Company Information Table 90. Bristol-Myers Squibb Business Overview Table 91. Bristol-Myers Squibb Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bristol-Myers Squibb Gatifloxacin Product Portfolio Table 93. Bristol-Myers Squibb Recent Development Table 94. Apotex Company Information Table 95. Apotex Business Overview Table 96. Apotex Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Apotex Gatifloxacin Product Portfolio Table 98. Apotex Recent Development Table 99. Allergan Company Information Table 100. Allergan Business Overview Table 101. Allergan Gatifloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Allergan Gatifloxacin Product Portfolio Table 103. Allergan Recent Development Table 104. North America Gatifloxacin Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Gatifloxacin Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Gatifloxacin Sales by Type (2021-2026) & (K Units) Table 107. North America Gatifloxacin Sales by Type (2027-2032) & (K Units) Table 108. North America Gatifloxacin Sales Price by Type (2021-2026) & (US$/Unit) Table 109. North America Gatifloxacin Sales Price by Type (2027-2032) & (US$/Unit) Table 110. North America Gatifloxacin Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Gatifloxacin Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Gatifloxacin Sales by Application (2021-2026) & (K Units) Table 113. North America Gatifloxacin Sales by Application (2027-2032) & (K Units) Table 114. North America Gatifloxacin Sales Price by Application (2021-2026) & (US$/Unit) Table 115. North America Gatifloxacin Sales Price by Application (2027-2032) & (US$/Unit) Table 116. North America Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Gatifloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Gatifloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Gatifloxacin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. North America Gatifloxacin Sales by Country (2021-2026) & (K Units) Table 121. North America Gatifloxacin Sales by Country (2027-2032) & (K Units) Table 122. North America Gatifloxacin Sales Price by Country (2021-2026) & (US$/Unit) Table 123. North America Gatifloxacin Sales Price by Country (2027-2032) & (US$/Unit) Table 124. United States Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 125. Canada Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 126. Europe Gatifloxacin Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Gatifloxacin Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Gatifloxacin Sales by Type (2021-2026) & (K Units) Table 129. Europe Gatifloxacin Sales by Type (2027-2032) & (K Units) Table 130. Europe Gatifloxacin Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Europe Gatifloxacin Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Europe Gatifloxacin Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Gatifloxacin Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Gatifloxacin Sales by Application (2021-2026) & (K Units) Table 135. Europe Gatifloxacin Sales by Application (2027-2032) & (K Units) Table 136. Europe Gatifloxacin Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Europe Gatifloxacin Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Europe Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Gatifloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Gatifloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Gatifloxacin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Europe Gatifloxacin Sales by Country (2021-2026) & (K Units) Table 143. Europe Gatifloxacin Sales by Country (2027-2032) & (K Units) Table 144. Europe Gatifloxacin Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Europe Gatifloxacin Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Germany Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 147. France Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 148. U.K. Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 149. Italy Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 151. China Gatifloxacin Revenue by Type (2021-2026) & (US$ Million) Table 152. China Gatifloxacin Revenue by Type (2027-2032) & (US$ Million) Table 153. China Gatifloxacin Sales by Type (2021-2026) & (K Units) Table 154. China Gatifloxacin Sales by Type (2027-2032) & (K Units) Table 155. China Gatifloxacin Sales Price by Type (2021-2026) & (US$/Unit) Table 156. China Gatifloxacin Sales Price by Type (2027-2032) & (US$/Unit) Table 157. China Gatifloxacin Revenue by Application (2021-2026) & (US$ Million) Table 158. China Gatifloxacin Revenue by Application (2027-2032) & (US$ Million) Table 159. China Gatifloxacin Sales by Application (2021-2026) & (K Units) Table 160. China Gatifloxacin Sales by Application (2027-2032) & (K Units) Table 161. China Gatifloxacin Sales Price by Application (2021-2026) & (US$/Unit) Table 162. China Gatifloxacin Sales Price by Application (2027-2032) & (US$/Unit) Table 163. Asia Gatifloxacin Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Gatifloxacin Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Gatifloxacin Sales by Type (2021-2026) & (K Units) Table 166. Asia Gatifloxacin Sales by Type (2027-2032) & (K Units) Table 167. Asia Gatifloxacin Sales Price by Type (2021-2026) & (US$/Unit) Table 168. Asia Gatifloxacin Sales Price by Type (2027-2032) & (US$/Unit) Table 169. Asia Gatifloxacin Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Gatifloxacin Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Gatifloxacin Sales by Application (2021-2026) & (K Units) Table 172. Asia Gatifloxacin Sales by Application (2027-2032) & (K Units) Table 173. Asia Gatifloxacin Sales Price by Application (2021-2026) & (US$/Unit) Table 174. Asia Gatifloxacin Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Gatifloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Gatifloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Gatifloxacin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. Asia Gatifloxacin Sales by Country (2021-2026) & (K Units) Table 180. Asia Gatifloxacin Sales by Country (2027-2032) & (K Units) Table 181. Asia Gatifloxacin Sales Price by Country (2021-2026) & (US$/Unit) Table 182. Asia Gatifloxacin Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Japan Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 184. South Korea Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 185. India Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 186. Australia Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 187. China Taiwan Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Gatifloxacin Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Gatifloxacin Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Gatifloxacin Sales by Type (2021-2026) & (K Units) Table 192. SAMEA Gatifloxacin Sales by Type (2027-2032) & (K Units) Table 193. SAMEA Gatifloxacin Sales Price by Type (2021-2026) & (US$/Unit) Table 194. SAMEA Gatifloxacin Sales Price by Type (2027-2032) & (US$/Unit) Table 195. SAMEA Gatifloxacin Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Gatifloxacin Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Gatifloxacin Sales by Application (2021-2026) & (K Units) Table 198. SAMEA Gatifloxacin Sales by Application (2027-2032) & (K Units) Table 199. SAMEA Gatifloxacin Sales Price by Application (2021-2026) & (US$/Unit) Table 200. SAMEA Gatifloxacin Sales Price by Application (2027-2032) & (US$/Unit) Table 201. SAMEA Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Gatifloxacin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Gatifloxacin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Gatifloxacin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 205. SAMEA Gatifloxacin Sales by Country (2021-2026) & (K Units) Table 206. SAMEA Gatifloxacin Sales by Country (2027-2032) & (K Units) Table 207. SAMEA Gatifloxacin Sales Price by Country (2021-2026) & (US$/Unit) Table 208. SAMEA Gatifloxacin Sales Price by Country (2027-2032) & (US$/Unit) Table 209. Brazil Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 210. Argentina Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 211. Chile Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 212. Colombia Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 213. Peru Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 215. Israel Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 216. UAE Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 217. Turkey Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 218. Iran Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 219. Egypt Gatifloxacin Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Gatifloxacin Distributors List Table 223. Gatifloxacin Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Gatifloxacin Image Figure 2. Global Gatifloxacin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gatifloxacin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Image Figure 5. Tablet Image Figure 6. Aqueous Solution Image Figure 7. Others Image Figure 8. Global Gatifloxacin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Gatifloxacin Market Size Share 2021 VS 2025 VS 2032 Figure 10. Synthetic Antibacterial Image Figure 11. Ophthalmic Medicine Image Figure 12. Other Image Figure 13. Global Gatifloxacin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gatifloxacin Revenue (2021-2032) & (US$ Million) Figure 15. Global Gatifloxacin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Gatifloxacin Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Gatifloxacin Revenue Market Share by Region (2021-2032) Figure 18. Global Gatifloxacin Sales (2021-2032) & (K Units) Figure 19. Global Gatifloxacin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Gatifloxacin Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Gatifloxacin Sales YoY (2021-2032) & (K Units) Figure 22. Europe Gatifloxacin Sales YoY (2021-2032) & (K Units) Figure 23. China Gatifloxacin Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Gatifloxacin Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Gatifloxacin Sales YoY (2021-2032) & (K Units) Figure 26. Global Gatifloxacin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Gatifloxacin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Gatifloxacin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Gatifloxacin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Gatifloxacin Revenue Market Share by Type (2021-2032) Figure 32. Global Gatifloxacin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Gatifloxacin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gatifloxacin Sales Market Share by Type (2021-2032) Figure 35. Global Gatifloxacin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Gatifloxacin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Gatifloxacin Revenue Market Share by Application (2021-2032) Figure 38. Global Gatifloxacin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Gatifloxacin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gatifloxacin Sales Market Share by Application (2021-2032) Figure 41. North America Gatifloxacin Revenue Share by Type (2021-2032) Figure 42. North America Gatifloxacin Sales Share by Type (2021-2032) Figure 43. North America Gatifloxacin Revenue Share by Application (2021-2032) Figure 44. North America Gatifloxacin Sales Share by Application (2021-2032) Figure 45. North America Gatifloxacin Revenue Share by Country (2021-2032) Figure 46. North America Gatifloxacin Sales Share by Country (2021-2032) Figure 47. Europe Gatifloxacin Revenue Share by Type (2021-2032) Figure 48. Europe Gatifloxacin Sales Share by Type (2021-2032) Figure 49. Europe Gatifloxacin Revenue Share by Application (2021-2032) Figure 50. Europe Gatifloxacin Sales Share by Application (2021-2032) Figure 51. Europe Gatifloxacin Revenue Share by Country (2021-2032) Figure 52. Europe Gatifloxacin Sales Share by Country (2021-2032) Figure 53. China Gatifloxacin Revenue Share by Type (2021-2032) Figure 54. China Gatifloxacin Sales Share by Type (2021-2032) Figure 55. China Gatifloxacin Revenue Share by Application (2021-2032) Figure 56. China Gatifloxacin Sales Share by Application (2021-2032) Figure 57. Asia Gatifloxacin Revenue Share by Type (2021-2032) Figure 58. Asia Gatifloxacin Sales Share by Type (2021-2032) Figure 59. Asia Gatifloxacin Revenue Share by Application (2021-2032) Figure 60. Asia Gatifloxacin Sales Share by Application (2021-2032) Figure 61. Asia Gatifloxacin Revenue Share by Country (2021-2032) Figure 62. Asia Gatifloxacin Sales Share by Country (2021-2032) Figure 63. SAMEA Gatifloxacin Revenue Share by Type (2021-2032) Figure 64. SAMEA Gatifloxacin Sales Share by Type (2021-2032) Figure 65. SAMEA Gatifloxacin Revenue Share by Application (2021-2032) Figure 66. SAMEA Gatifloxacin Sales Share by Application (2021-2032) Figure 67. SAMEA Gatifloxacin Revenue Share by Country (2021-2032) Figure 68. SAMEA Gatifloxacin Sales Share by Country (2021-2032) Figure 69. Gatifloxacin Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Gatifloxacin Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
  • Aqueous Solution
  • Others
Applications
  • Synthetic Antibacterial
  • Ophthalmic Medicine
  • Other
Companies covered
  • Teva Pharmaceuticals
  • Sandoz
  • Mylan
  • Pacific Pharma
  • Lupin Pharmaceuticals
  • Hi Tech Pharmacal
  • Bristol-Myers Squibb
  • Apotex
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gatifloxacin Market by Type
  3. 1.2.1 Global Gatifloxacin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Tablet
  6. 1.2.4 Aqueous Solution
  7. 1.2.5 Others
  8. 1.3 Gatifloxacin Market by Application
  9. 1.3.1 Global Gatifloxacin Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Synthetic Antibacterial
  11. 1.3.3 Ophthalmic Medicine
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gatifloxacin Market Dynamics
  1. 2.1 Gatifloxacin Industry Trends
  2. 2.2 Gatifloxacin Industry Drivers
  3. 2.3 Gatifloxacin Industry Opportunities and Challenges
  4. 2.4 Gatifloxacin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gatifloxacin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gatifloxacin Revenue by Region
  3. 3.2.1 Global Gatifloxacin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gatifloxacin Revenue by Region (2021-2026)
  5. 3.2.3 Global Gatifloxacin Revenue by Region (2027-2032)
  6. 3.2.4 Global Gatifloxacin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gatifloxacin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gatifloxacin Sales by Region
  9. 3.4.1 Global Gatifloxacin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gatifloxacin Sales by Region (2021-2026)
  11. 3.4.3 Global Gatifloxacin Sales by Region (2027-2032)
  12. 3.4.4 Global Gatifloxacin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gatifloxacin Revenue by Manufacturers
  2. 4.1.1 Global Gatifloxacin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gatifloxacin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gatifloxacin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gatifloxacin Sales by Manufacturers
  6. 4.2.1 Global Gatifloxacin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gatifloxacin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gatifloxacin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gatifloxacin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gatifloxacin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gatifloxacin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gatifloxacin Manufacturers, Product Type & Application
  13. 4.7 Global Gatifloxacin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gatifloxacin Market CR5 and HHI
  16. 4.8.2 2025 Gatifloxacin Tier 1, Tier 2, and Tier 3
5 Gatifloxacin Market by Type
  1. 5.1 Global Gatifloxacin Revenue by Type
  2. 5.1.1 Global Gatifloxacin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gatifloxacin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gatifloxacin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gatifloxacin Sales by Type
  6. 5.2.1 Global Gatifloxacin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gatifloxacin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gatifloxacin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gatifloxacin Price by Type
6 Gatifloxacin Market by Application
  1. 6.1 Global Gatifloxacin Revenue by Application
  2. 6.1.1 Global Gatifloxacin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gatifloxacin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gatifloxacin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gatifloxacin Sales by Application
  6. 6.2.1 Global Gatifloxacin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gatifloxacin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gatifloxacin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gatifloxacin Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceuticals
  2. 7.1.1 Teva Pharmaceuticals Company Information
  3. 7.1.2 Teva Pharmaceuticals Business Overview
  4. 7.1.3 Teva Pharmaceuticals Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceuticals Gatifloxacin Product Portfolio
  6. 7.1.5 Teva Pharmaceuticals Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Gatifloxacin Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Gatifloxacin Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Pacific Pharma
  20. 7.4.1 Pacific Pharma Company Information
  21. 7.4.2 Pacific Pharma Business Overview
  22. 7.4.3 Pacific Pharma Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pacific Pharma Gatifloxacin Product Portfolio
  24. 7.4.5 Pacific Pharma Recent Developments
  25. 7.5 Lupin Pharmaceuticals
  26. 7.5.1 Lupin Pharmaceuticals Company Information
  27. 7.5.2 Lupin Pharmaceuticals Business Overview
  28. 7.5.3 Lupin Pharmaceuticals Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lupin Pharmaceuticals Gatifloxacin Product Portfolio
  30. 7.5.5 Lupin Pharmaceuticals Recent Developments
  31. 7.6 Hi Tech Pharmacal
  32. 7.6.1 Hi Tech Pharmacal Company Information
  33. 7.6.2 Hi Tech Pharmacal Business Overview
  34. 7.6.3 Hi Tech Pharmacal Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hi Tech Pharmacal Gatifloxacin Product Portfolio
  36. 7.6.5 Hi Tech Pharmacal Recent Developments
  37. 7.7 Bristol-Myers Squibb
  38. 7.7.1 Bristol-Myers Squibb Company Information
  39. 7.7.2 Bristol-Myers Squibb Business Overview
  40. 7.7.3 Bristol-Myers Squibb Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bristol-Myers Squibb Gatifloxacin Product Portfolio
  42. 7.7.5 Bristol-Myers Squibb Recent Developments
  43. 7.8 Apotex
  44. 7.8.1 Apotex Company Information
  45. 7.8.2 Apotex Business Overview
  46. 7.8.3 Apotex Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Apotex Gatifloxacin Product Portfolio
  48. 7.8.5 Apotex Recent Developments
  49. 7.9 Allergan
  50. 7.9.1 Allergan Company Information
  51. 7.9.2 Allergan Business Overview
  52. 7.9.3 Allergan Gatifloxacin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Allergan Gatifloxacin Product Portfolio
  54. 7.9.5 Allergan Recent Developments
8 North America
  1. 8.1 North America Gatifloxacin Market Size by Type
  2. 8.1.1 North America Gatifloxacin Revenue by Type (2021-2032)
  3. 8.1.2 North America Gatifloxacin Sales by Type (2021-2032)
  4. 8.1.3 North America Gatifloxacin Price by Type (2021-2032)
  5. 8.2 North America Gatifloxacin Market Size by Application
  6. 8.2.1 North America Gatifloxacin Revenue by Application (2021-2032)
  7. 8.2.2 North America Gatifloxacin Sales by Application (2021-2032)
  8. 8.2.3 North America Gatifloxacin Price by Application (2021-2032)
  9. 8.3 North America Gatifloxacin Market Size by Country
  10. 8.3.1 North America Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gatifloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gatifloxacin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gatifloxacin Market Size by Type
  2. 9.1.1 Europe Gatifloxacin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gatifloxacin Sales by Type (2021-2032)
  4. 9.1.3 Europe Gatifloxacin Price by Type (2021-2032)
  5. 9.2 Europe Gatifloxacin Market Size by Application
  6. 9.2.1 Europe Gatifloxacin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gatifloxacin Sales by Application (2021-2032)
  8. 9.2.3 Europe Gatifloxacin Price by Application (2021-2032)
  9. 9.3 Europe Gatifloxacin Market Size by Country
  10. 9.3.1 Europe Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gatifloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gatifloxacin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gatifloxacin Market Size by Type
  2. 10.1.1 China Gatifloxacin Revenue by Type (2021-2032)
  3. 10.1.2 China Gatifloxacin Sales by Type (2021-2032)
  4. 10.1.3 China Gatifloxacin Price by Type (2021-2032)
  5. 10.2 China Gatifloxacin Market Size by Application
  6. 10.2.1 China Gatifloxacin Revenue by Application (2021-2032)
  7. 10.2.2 China Gatifloxacin Sales by Application (2021-2032)
  8. 10.2.3 China Gatifloxacin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gatifloxacin Market Size by Type
  2. 11.1.1 Asia Gatifloxacin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gatifloxacin Sales by Type (2021-2032)
  4. 11.1.3 Asia Gatifloxacin Price by Type (2021-2032)
  5. 11.2 Asia Gatifloxacin Market Size by Application
  6. 11.2.1 Asia Gatifloxacin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gatifloxacin Sales by Application (2021-2032)
  8. 11.2.3 Asia Gatifloxacin Price by Application (2021-2032)
  9. 11.3 Asia Gatifloxacin Market Size by Country
  10. 11.3.1 Asia Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gatifloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gatifloxacin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gatifloxacin Market Size by Type
  2. 12.1.1 SAMEA Gatifloxacin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gatifloxacin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gatifloxacin Price by Type (2021-2032)
  5. 12.2 SAMEA Gatifloxacin Market Size by Application
  6. 12.2.1 SAMEA Gatifloxacin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gatifloxacin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gatifloxacin Price by Application (2021-2032)
  9. 12.3 SAMEA Gatifloxacin Market Size by Country
  10. 12.3.1 SAMEA Gatifloxacin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gatifloxacin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gatifloxacin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gatifloxacin Value Chain Analysis
  2. 13.1.1 Gatifloxacin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gatifloxacin Production Mode & Process
  6. 13.2 Gatifloxacin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gatifloxacin Distributors
  9. 13.2.3 Gatifloxacin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst